WebApr 12, 2024 · In vivo FEN1/DNA-PKcs synthetic lethality We next assessed whether combination treatment with FEN1 and the DNA-PKcs inhibitors sc-13 and NU-7441 can … WebMar 3, 2009 · FEN1 down-regulation underlies synthetic lethality in RAD54B-deficient human cells. ( A) Graphical representation of the percentages of cells relative to GAPD knockdown (± SEM) are shown for the isogenic RAD54B +/+/+ and RAD54B −/−/− cells treated with the various siRNAs indicated ( x -axis).
Replication gaps are a key determinant of PARP inhibitor synthetic ...
WebA synthetic lethal interaction occurs when the con- current perturbation of two nonessential genes leads to cell death. Synthetic lethality (SL) is of great interest in the context of cancer therapies, as a cancer har- boring a mutation in a nonessential gene could be treated by pharmacological inhibition of a second nonessential gene. WebApr 14, 2024 · FEN1 was shown to have a synthetic lethal interaction in BRCA2 deficient cells compared to BRCA2 proficient cells. Increased sensitivity to an N-hydroxyurea-based FEN1 inhibitor was also evident in BRCA2 deficient cells in that study . In the current study, we have confirmed synthetic lethality using a different FEN1 inhibitor (3-hydroxy-5 ... hertz rental car omaha
Synthetic Lethality and Cancer – Penetrance as the Major Barrier
Weband the flap endonuclease FEN1 to be synthetic lethal with BRCA2 deficiency; the base excision repair (BER) pathway was synthetic lethal overall. We demonstrated that FEN1 plays a role in microhomology-mediated end joining (MMEJ) and that a FEN1 inhibitor selectively targets BRCA-deficient cells, offering therapeutic potential in the WebApr 15, 2011 · Abstract. Flap endonuclease-1 (FEN-1) is a 5′-3’ exonuclease and a 5’ flap endonuclease, required for Okazaki fragment processing as well as for long-patch base-excision repair (BER) and non-homologous end-joining (NHEJ). From datamining AstraZeneca's extensive GeAZR database, as well as from Oncomine searches, FEN-1 … WebThus, we designed a series of genetic screens to identify B2SL targets. We identified several B2SL genes and pathways whose inactivation exhibits stronger synthetic lethality with BRCA2 loss of function than PARP1 … mayo clinic pre surgery weight loss diet